Thursday, 1 October 2026

When Great Research Never Gets the Chance to Be Seen.

                                     

SOME RESEARCH IS NEVER SEEN. NOT BECAUSE IT ISN’T GOOD ENOUGH.

Somewhere, a young researcher may have spent months working on a study they deeply believe in. Late nights with data, repeated experiments, difficult revisions and the quiet hope that one day someone beyond their own institution will read their work and understand why it matters.

Then comes the conference.

The abstract is ready. The research is ready. The researcher is ready.

But life can get in the way. A clinical commitment cannot be postponed. An academic responsibility takes priority. Travel becomes difficult. Institutional circumstances change. For some, financial limitations add another barrier.

And the presentation that was supposed to happen simply doesn't.

The work stays in a file. The researcher moves on. The wider scientific community may never know that the study existed.

THIS WORLD THROMBOSIS DAY, WE WANT TO CHANGE ONE SUCH STORY.

From 1–13 October 2026, in recognition of World Thrombosis Day on 13 October, Hematology 2027 is introducing a participation initiative:

FOR EVERY 10 REGISTRATIONS, WE WILL SUPPORT 1 STUDENT WITH WELL-DESERVING, OUTSTANDING RESEARCH.

The initiative will consider students whose research demonstrates strong scientific merit and deserves to be presented to a wider scientific audience, particularly where financial circumstances may otherwise prevent participation.

10 registrations → 1 student supported
20 registrations → 2 students supported
30 registrations → 3 students supported

It may seem like a small number. But behind every number is a person who finally gets to put their work in front of people who can listen, question, respond and remember it.

BECAUSE SOMETIMES, WHAT HURTS MOST IS NOT THAT THE RESEARCH FAILED.

It is knowing that nobody got to see it.

Hematology 2027 will also feature a Young Researcher Award, recognising emerging researchers whose work demonstrates meaningful scientific contribution and encouraging them to keep asking the questions that science still needs answered.

Your registration is your participation in Hematology 2027. But during this campaign, it can also help make participation possible for another young researcher whose work deserves to be heard.

One registration may feel small. Together, they can give more research a way forward.

LET THEIR WORK HAVE ITS MOMENT.


Hematology 2027
4th International Summit on Hematology and Blood Disorders
15–16 March 2027 | Paris, France

Campaign: 1–13 October 2026
World Thrombosis Day: 13 October

Friday, 25 September 2026

4th International Summit on Haematology and Blood Disorders

 About the Conference

The 4th International Summit on Haematology and Blood Disorders, Mar 15-16, 2027 invites hematologists, physicians, healthcare professionals, researchers, academicians, laboratory specialists, students, pharmaceutical professionals, biotechnologists, and industry experts from around the world to join us in Paris, France.
With the theme “Innovative Approaches and Global Perspectives in Hematology”, the conference will provide a platform to explore recent developments, emerging trends, and innovative approaches in haematology and blood disorders. The conference will bring experts together to present research, exchange knowledge, discuss advances in diagnosis and treatment, and foster meaningful scientific collaboration.

Why to Join?

  1. Stay informed about the latest trends and developments.
  2. Connect with international experts and researchers
  3. Explore emerging diagnostic and treatment approaches
  4. Present your research and exchange knowledge
  5. Build valuable international collaborations
  6. Opportunity to have accepted abstracts featured in the conference proceedings or associated publication channels
  7. Receive a certificate recognizing your contribution and participation
  8. Enjoy a professional conference experience in Paris, France

Conference Highlights

  1. Scientific Insights — Current research and clinical developments
  2. Expert Sessions — Perspectives from researchers and healthcare professionals
  3. Research Exchange — Presentations and knowledge sharing
  4. Emerging Advances — New approaches in diagnosis and treatment
  5. Professional Networking — Opportunities for collaboration and discussion

Target audience:

  1. Hematologists, Physicians, and Medical Oncologists
  2. Researchers, Clinical Scientists, and Academicians
  3. Pathologists and Laboratory Professionals
  4. Pharmaceutical and Biotechnology Professionals
  5. Nurses and Allied Healthcare Professionals
  6. Students, Research Scholars, and Postdoctoral Fellows
  7. Blood Bank and Transfusion Medicine Professionals
  8. Stem Cell and Cellular Therapy Researchers
  9. Hospital and Industry Professionals
  10. Associations and Research Organizations
  11. Clinical Trial and Drug Development Professionals
  12. Genomics and Molecular Biology Specialists
  13. Healthcare Administrators and Hospital Managers
  14. Medical Technology and Diagnostic Experts
  15. Public Health and Epidemiology Professionals